Literature DB >> 20368706

CYP2D6 in the brain: genotype effects on resting brain perfusion.

J Kirchheiner1, A Seeringer, A L Godoy, B Ohmle, C Maier, P Beschoner, E-J Sim, R Viviani.   

Abstract

The cytochrome P450 2D6 (CYP2D6) is a genetically polymorphic enzyme involved in the metabolism of several psychoactive drugs. Beside its expression in the liver, CYP2D6 is highly expressed in several regions of the brain, such as the hippocampus, thalamus, hypothalamus and the cortex, but its function in the brain is not well understood. The CYP2D6 enzyme may also have a physiological role due to its involvement in neurotransmitter biotransformation. In this study, CYP2D6 genotyping was performed in N=188 healthy individuals and compared with brain perfusion levels at rest, which may reflect an ongoing biological process regulating the reactivity of the individual to emotional stimuli and the detection of signals evoking fear. Relative to N=42 matched extensive metabolizers, N=14 poor metabolizers were associated with 15% higher perfusion levels in the thalamus (P=0.03 and 0.003). Effects were also present in the whole (N=188) sample divided into metabolizer groups, or finely graded into seven CYP2D6 activity levels. A weaker effect was observed in the right hippocampus (P=0.05). An exploratory analysis, extended to the whole brain, suggested the involvement of CYP2D6 in regions associated with alertness or serotonergic function. These findings support the hypothesis of a functional role of CYP2D6 in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368706     DOI: 10.1038/mp.2010.42

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  13 in total

Review 1.  CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

Authors:  Eva M Peñas-Lledó; Adrián Llerena
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 2.  Transcriptional Regulation of CYP2D6 Expression.

Authors:  Xian Pan; Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2016-10-03       Impact factor: 3.922

Review 3.  Cytochrome P450-mediated drug metabolism in the brain.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

Review 4.  Use of magnetic resonance imaging in pharmacogenomics.

Authors:  Roberto Viviani; Marie-Louise Lehmann; Julia C Stingl
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

5.  Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.

Authors:  R T Miller; S Miksys; E Hoffmann; R F Tyndale
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice.

Authors:  Miaoran Ning; Kwi Hye Koh; Xian Pan; Hyunyoung Jeong
Journal:  Biochem Pharmacol       Date:  2015-01-15       Impact factor: 5.858

Review 7.  Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

Authors:  Charmaine S Ferguson; Rachel F Tyndale
Journal:  Trends Pharmacol Sci       Date:  2011-10-03       Impact factor: 14.819

8.  Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.

Authors:  Jibran Y Khokhar; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

9.  Krüppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice.

Authors:  Kwi Hye Koh; Xian Pan; Wei Zhang; Alan McLachlan; Raul Urrutia; Hyunyoung Jeong
Journal:  Mol Pharmacol       Date:  2014-09-12       Impact factor: 4.436

10.  Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Cole Tolledo; Marlaina R Stocco; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-03-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.